Thymosin Beta-4 Improves Fat Graft Survival and Blood Vessel Formation in Rabbits
Adding thymosin beta-4 to fat grafts improved their volume retention, tissue integrity, and blood vessel formation in a rabbit ear model over 12 weeks.
Quick Facts
What This Study Found
Tβ4-treated fat grafts showed superior volume retention, weight preservation, adipocyte viability, tissue integrity, and angiogenesis at 2, 4, and 12 weeks compared to controls, with enhanced microcirculation confirmed by DCE-MRI.
Key Numbers
5 and 10 mcg/mL Tb4; MRI at 2, 4, 12 weeks; better volume/weight retention, adipocyte viability, angiogenesis, microcirculation
How They Did This
Rabbit ear fat grafting model with 3 randomized groups: 5 μg/mL Tβ4, 10 μg/mL Tβ4, and PBS control. MRI imaging at 2, 4, and 12 weeks. Histological analysis of adipose tissue integrity, viability, and angiogenesis at each time point.
Why This Research Matters
Fat grafting is widely used in reconstructive and cosmetic surgery but has unpredictable survival rates. A simple additive like Tβ4 could significantly improve outcomes without changing the surgical procedure.
The Bigger Picture
This study extends thymosin beta-4's known wound healing and angiogenic properties into the plastic surgery domain, where improving fat graft survival is a major clinical need affecting millions of procedures annually.
What This Study Doesn't Tell Us
Preliminary rabbit study with small, unspecified group sizes. Rabbit ear fat grafting may not perfectly model human facial or body fat grafting. Long-term retention beyond 12 weeks not assessed.
Questions This Raises
- ?What is the optimal Tβ4 concentration for maximizing human fat graft survival?
- ?Does Tβ4 prevent fat graft resorption long-term beyond 12 weeks?
- ?Could Tβ4 be combined with other growth factors to further improve graft outcomes?
Trust & Context
- Key Stat:
- Better survival at 12 weeks Tβ4-treated fat grafts maintained superior volume, weight, and tissue integrity through 12 weeks of follow-up
- Evidence Grade:
- Preliminary — small rabbit study with promising results but no human data or large-animal validation.
- Study Age:
- Published in 2020; Tβ4 for fat graft enhancement remains a promising area needing clinical translation.
- Original Title:
- The Effect of Thymosin beta4 on the Survival of Autologous Fat Grafting: A Preliminary Study.
- Published In:
- Aesthetic surgery journal, 40(9), NP519-NP529 (2020)
- Authors:
- Qu, Yaping, Wang, Qian(6), Fu, Su, Guo, Xiaoshuang, Luan, Jie, Mu, Dali
- Database ID:
- RPEP-05084
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
Why do fat grafts often fail?
Transplanted fat tissue often loses volume because the cells die before new blood vessels can grow to supply them. Without adequate blood flow, much of the grafted fat is reabsorbed by the body over weeks to months.
How does thymosin beta-4 help fat grafts survive?
Tβ4 promotes new blood vessel formation (angiogenesis), reduces cell death (apoptosis), and decreases inflammation — all factors that help transplanted fat cells survive until they establish their own blood supply.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-05084APA
Qu, Yaping; Wang, Qian; Fu, Su; Guo, Xiaoshuang; Luan, Jie; Mu, Dali. (2020). The Effect of Thymosin beta4 on the Survival of Autologous Fat Grafting: A Preliminary Study.. Aesthetic surgery journal, 40(9), NP519-NP529. https://doi.org/10.1093/asj/sjaa062
MLA
Qu, Yaping, et al. "The Effect of Thymosin beta4 on the Survival of Autologous Fat Grafting: A Preliminary Study.." Aesthetic surgery journal, 2020. https://doi.org/10.1093/asj/sjaa062
RethinkPeptides
RethinkPeptides Research Database. "The Effect of Thymosin beta4 on the Survival of Autologous F..." RPEP-05084. Retrieved from https://rethinkpeptides.com/research/qu-2020-the-effect-of-thymosin
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.